Remove FDA Remove Governance Remove Licensing Remove Pharmaceutical Industry
article thumbnail

Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment

Bill of Health

Such a provision could prevent the public from paying twice for publicly-funded medical products—first through their taxes subsidizing government funded research and development, and second to procure the product in an inflated U.S. pharmaceutical market. Moreover, the NASDAQ Biotechnology Index increased by 374% from 1995 to 2000.

COVID-19 205
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

This standard is a globally recognized standard that provides guidelines for the governance and management of AI technologies. It provides a practical guide for the pharmaceutical industry on how to implement PACs within the framework of an effective Pharmaceutical Quality System (PQS) and in alignment with ICH quality guidelines.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

Nevada, currently the wild west of birthing, is considering licensing midwifery NEW HAMPSHIRE Dartmouth Health opens new 5-story patient pavilion Report: Anthem has yet to process nearly $300 million in N.H. no longer calls for masks at all health care facilities to fight COVID-19, Gov.

article thumbnail

Shameless Plug: Reed Smith’s Virtual Life Sciences Litigation CLE Day (Nov. 16)

Drug & Device Law

Learn an important preemption decision for our FDA-regulated sandbox that did not involve any of these products (and now has dodged a potential Supreme Court bullet). Attendees who are licensed in other jurisdictions will receive a uniform certificate of attendance but Reed Smith only provides credit for the states listed.

FDA 59